ClinicalTrials.gg
RecruitingNCT06330467IDENTITYUpdated Apr 24, 2026

Prevalence of Dissociative Identity Disorder in At-risk Outpatient Groups Reporting Childhood Trauma.

An interventional study of psychometric assessment and semi-structured clinical interview in Dissociative Disorder, sponsored by Centre Psychothérapique de Nancy. Recruiting at 3 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-24.

Sponsored by Centre Psychothérapique de Nancy · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators will study the prevalence of dissociative identity disorder (DID) in three populations at risk in cases of childhood psychotrauma : patients with a diagnosis of borderline personality, patients with a diagnosis of functional dissociative crises (FDC) and patients with early psychosis.

The investigators will also study the prevalence of other dissociative disorders and the frequency of complex post-traumatic stress disorder.

The investigators will also look for correlations between the type of maltreatment in childhood, the age of onset of trauma and the type of diagnosis of dissociative disorders.

The investigators hope to include 150 borderline patients, 150 FDC patients and 50 early psychosis patients.

Data collection will be done via a psychometric administration of 7 self-completion questionnaires as well as the completion of the SCID-D semi-structured interview.

02

Conditions studied

  • Dissociative Disorder

Keywords

  • Dissociative Identity Disorder (DID)
  • Psychosis
  • Functional Dissociative Crises (FDC)
  • Complex PTSD
  • Borderline
03

In context

Dissociative Disorders

41 studies on the registry are indexed under Dissociative Disorders; 13 are open to participants now.

This study's planned enrollment of 350 is above the median of 50 across 34 interventional studies indexed under Dissociative Disorders.

Browse Dissociative Disorders studies →

Lead sponsor

Centre Psychothérapique de Nancy is the lead sponsor of 19 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

I - Inclusion Criteria:

I-1: For all groups:

  • Male or female
  • Age > or = 18
  • Enrolled in or benefiting from a social security scheme
  • Patient fluent in French
  • Patient willing to undergo a psychological evaluation between 1h30 and 3h30
  • Patient with a known history of psychotrauma in childhood before the age of 18 (sexual abuse, mistreatment, school harassment, natural disasters, attacks, etc.).
  • Patient having received and understood complete information on the organization of the research and having given written free and prior to participation in the study.

I-2 : Patients in the borderline group

  • Patients with main diagnosis of emotionally labile personality
  • Patients with at least one psychiatric hospitalization in the last 3 years

I-3 : Patients in the early psychosis group

Patient with a diagnosis of mental state at risk of psychosis according to the criteria defined by CAARMS (Comprehensive Assessment of At Risk Mental State) OR Patients diagnosed with a first psychotic episode on an outpatient basis or following a hospital stay

I-4 : Patients in the functional dissociative crises group

Patients diagnosed with functional dissociative crises by a specialized epileptologist

II- Non-inclusion criteria

  • Impairment of the subject making it difficult or not impossible to participate in the trial or to understand the information provided to him/her
  • Patients with specific difficulties in understanding SCID-D questions
  • Psychiatric condition requiring hospitalization
  • Patients with symptoms of recent toxic consumption (alcohol, cannabis, other ...) disrupting assessment responses
  • Patient taking part in a pharmacological study involving a pro-dissociative molecule of the psychedelic type
  • Pregnant, parturient or nursing mothers
  • Person deprived of liberty by judicial or administrative decision
  • Person in a life-threatening emergency
  • An adult under legal protection (guardianship, curatorship, safeguard of justice)
  • Person unable to give consent and not subject to a legal protection measure
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
350 participants (estimated)

Study arms

  • Other
    Borderline

    Borderline patients

    Diagnostic Test: psychometric assessment · Diagnostic Test: semi-structured clinical interview

  • Other
    Functional Dissociative Crises (FDC)

    FDC patients

    Diagnostic Test: psychometric assessment · Diagnostic Test: semi-structured clinical interview

  • Other
    Early psychosis

    Early psychosis patients : mental state at risk for psychosis and first psychotic episode

    Diagnostic Test: psychometric assessment · Diagnostic Test: semi-structured clinical interview

Interventions

  • Diagnostic testpsychometric assessment

    Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.

  • Diagnostic testsemi-structured clinical interview

    Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)

06

What researchers measure

Primary outcomes

  1. SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders / DSM = Diagnostic and Statistical Manual of Mental Disorders / ICD = International Classification of Diseases

    assesses the dissociative identity disorder

    Time frame: Inclusion visit

Secondary outcomes

  1. SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders

    assesses the 4 others domains of dissociative disorders

    Time frame: Inclusion visit

  2. CTQ-28 : Childhood Trauma Questionnaire

    assesses history of childhood abuse and childhood trauma. For the CTQ-28, the overall score is not really relevant, but rather the scores for each type of abuse. For each type of maltreatment, there are differences in severity, ranging from "none" to "severe", with threshold scores for each level. In fact, there is no real overall minimum or maximum score.

    Time frame: Inclusion visit

  3. life events inventory DSM-5

    assesses history of potentially traumatic life events. There is no numerical score, it's simply an inventory of potentially traumatic life events.

    Time frame: Inclusion visit

  4. PCL-5 : Posttraumatic stress disorder CheckList-5

    assess the Post Traumatic Stress Disorder. For the PCL-5, the threshold score is 33, so a score of 33 or more suggests the presence of PTSD : the higher the score, the greater the symptomatology. The score is not a value used for interpretation purposes. The investigators use only threshold scores, or diagnostic criteria.

    Time frame: Inclusion visit

  5. ITQ : International Trauma Questionnaire

    assesses simple and complex post-traumatic stress syndrome. For the ITQ, there is no real numerical score; the diagnosis of PTSD or complex PTSD is made on the basis of the diagnostic criteria met. Scores are not given with numbers, but only with the presence or absence of simple or complex PTSD. There is no minimum or maximum score.

    Time frame: Inclusion visit

  6. SDQ-20 : Somatoform Dissociative questionnaire

    assess somatoform dissociation. For the SDQ-20, the threshold score is 28, and there are no levels of severity: the higher the score, the more severe the somatoform dissociative disorders. However, the score should be treated with caution, as if the symptoms reported by the patient are explained by a medical cause, we cannot conclude that dissociative disorders are present despite the score.

    Time frame: Inclusion visit

  7. DIS-Q : Dissociation Questionnaire

    assess the dissociative disorders. For the DIS-Q, the threshold score is 2.5. The score is not a value used for interpretation purposes. The investigators use only threshold scores, or diagnostic criteria.

    Time frame: Inclusion visit

  8. DES : Dissociative Experience Scale

    assess the dissociative disorder. For the DES, there is a threshold score of 15, and the higher the score, the more severe the dissociative disorders, but there are no multiple levels of severity. The score is not a value used for interpretation purposes. The investigators use only threshold scores, or diagnostic criteria.

    Time frame: Inclusion visit

07

Study locations

2 of 3 sites recruiting
  • Centre Psychothérapique de Nancy - CLIP
    Nancy, France
    Not yet recruiting
  • Centre Psychothérapique de Nancy - CMP Jacquard et Des Près
    Nancy, France
    Recruiting
  • CHRU Nancy - Neurology department
    Nancy, France
    Recruiting
    • Coraline HINGRAY · Contactcoraline.hingray@cpn-laxou.com
    • Coraline HINGRAY · Principal investigator
    • Alexis TARRADA · Sub investigator
    • Séverine CONRADI · Sub investigator
    • Lori PETROCELLI · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06330467
Lead sponsor
Centre Psychothérapique de Nancy
Responsible party
Sponsor
First posted
Mar 26, 2024
Start date
Jun 4, 2024
Primary completion
Aug 18, 2026 (estimated)
Completion
Aug 18, 2026 (estimated)
Last update
Apr 24, 2026

Study contacts

Lori PETROCELLI
Contact
petrocelli.psy@gmail.com
+33383852377
Tatiana DABROWSKI
Contact
unic@cpn-laxou.com
+33383925349
Coraline HINGRAY
principal investigator · Centre Psychothérapique de Nancy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion